Ehlers-Danlos Syndrome Clinical Presentation
- Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD more...
The biochemical collagen defect is present at birth, but clinical manifestations become evident later. Regrettably, the value of clinical tests for generalized joint hypermobility, Ehlers-Danlos syndrome, hypermobility type, and joint hypermobility syndrome may be less than ideal. The skin findings provide the diagnostic criterion of Ehlers-Danlos syndrome, hypermobility type and joint hypermobility syndrome; there is no supportive laboratory test.
Muscle weakness is often present, and patients report a tendency to fall down easily and have poor body control. Sometimes, patients have difficulty walking.
Mental development is normal.
The newly described tenascin-X–deficient form was described in 8 patients with hyperelastic skin and hypermobile joints. Each patient bruised easily, and most had velvety skin. A few patients also had joint pain and multiple subluxations. None had delayed wound healing or atrophic scars. Additional findings in some patients included congenital adrenal hyperplasia, mitral valvular prolapse, stroke, gut bleeding, and premature arteriosclerosis.
Dental pathology is common in these patients. Findings include hypodontia of permanent teeth, delayed eruption, and dentin dysplasia.
In one patient, splenic rupture due to peliosis led to the diagnosis of vascular Ehlers-Danlos syndrome.
Two Ehlers-Danlos syndrome patients with cutaneous metaplastic synovial cysts are described in the literature.
Multiple sclerosis can be associated with Ehlers-Danlos syndrome.
Absence of the inferior labial or lingual frenula in Ehlers-Danlos syndrome patients has been suggested as a new diagnostic criterion.
Baba et al showed an association of Ehlers-Danlos syndrome and solitary rectal ulcer syndrome.
Subependymal periventricular heterotopia is not a rarity in Ehlers-Danlos syndrome patients.
Several articles review pregnancy in Ehlers-Danlos syndrome patients.
To date, 11 variants of Ehlers-Danlos syndrome are identified; all have genetic, biochemical, and clinical differences. More than one third of persons with Ehlers-Danlos syndrome do not fit exactly into a single type; overlap is common.
Common to almost all groups is a unique appearance of the skin (see the images below).
The skin is usually white and soft, and underlying vessels are sometimes visible. The skin has a doughy feel. The skin is easily hyperextensible. It is easy to pull, and, once released, it immediately returns to its original state.
Molluscoid pseudotumors are small, spongy tumors found over scars and pressure points. Molluscoid pseudotumors consist of fat surrounded by a fibrous capsule. They are commonly seen in patients with type I.
Smaller, deep, palpable, and movable nodules are often present in the subcutaneous tissue. These nodules can be found in the arms and over the tibias. Calcification leads to opacity on radiographs.
Fragility of dermal skin is common, with frequent bruises and lacerations. Poor wound healing is not rare. The use of sutures is usually a problem in patients, in whom easy dehiscence and cigarette-paper–like scars may be observed. Frequently, these scars are found on the knees.
The joints are hyperextensible, sometimes dramatically, but the degree of involvement is variable. The digit joints are most commonly affected, but all the joints can show alterations. Dislocations can occur, but patients are usually able to quickly reduce them with no pain.
Type I - Gravis form
Type I, the gravis form, affects 43% of patients and is inherited in an autosomal dominant pattern. In this type, the clinical features are usually severe.
Patients have marked skin extensibility with frequent lacerations and subsequent scarring in different body locations. Surgical sutures heal poorly, with easy dehiscence.
Joint hypermobility is severe and affects all parts of the body. Spontaneous dislocations can occur, but immediate reduction is easy.
Varicosities and molluscoid pseudotumors are common. Musculoskeletal features are easily found. These features include kyphoscoliosis, hallus valgus, pes planus (ie, flat feet), and genu recurvatum; bruises are less common in this type than in other forms.
Cardiac defects, especially mitral valvular prolapse, are sometimes present. However, according to a retrospective cross-sectional and longitudinal chart analysis of 252 patients with types I, II, and III, mitral valvular prolapse and aortic root dilation were of little clinical significance in these forms of Ehlers-Danlos syndrome.
Prematurity with rupture of the fetal membranes is specific to this type.
Type II - Mitis form
Type II, the mitis form, affects 35% of patients and is inherited in an autosomal dominant pattern. This group is characterized by a mild appearance of the same features of type I. Wide scars are common, but the skin has somewhat less fragility and bruisability. The joints are moderately hyperextensible, and the digits are usually the only body sites affected.
Type III - Benign familiar hypermobile form
Type III, the benign familiar hypermobile form, affects 10% of patients and is inherited in an autosomal dominant pattern. Patients with this variant have minimal or no skin changes, but they do have a striking hyperextensibility in many joints. This hyperextensibility usually causes orthopedic consequences (eg, severe osteoarthritis) in the long term.
The hypermobility type of Ehlers-Danlos syndrome may be associated with uterine, rectal, ovarian, and/or heart prolapse, although multiple visceral ptoses are rare. An MRI study of this hypermobility type showed consistent and specific white matter findings after physical trauma.
Type IV - Ecchymotic or arterial form
Type IV, the ecchymotic or arterial form, affects 6% of patients and is inherited in an autosomal recessive or sometimes autosomal dominant pattern. This variant is relatively rare.
Clinically, patients have unique, white, translucent skin, and the underlying vessels are easy to see. The skin is also fragile but not extensible. Scars and molluscoid pseudotumors are numerous, as are bruises and purpuric lesions. Keloids and hyperpigmentation of the scars are common.
Joint hyperextensibility is rare or absent. Arterial aneurysms, valvular prolapse, and spontaneous pneumothorax are common complications. Patients also have low weight and short stature.
The prognosis for this type is poor, and the patient's life span is shortened. Sudden death can occur after visceral perforation or after the rupture of a large vessel, most commonly an abdominal or splenic vessel.
A prenatal diagnosis by means of polymorphic restriction genetic studies is possible.
Type V - X-linked form
Type V, the X-linked form, affects 5% of patients and is inherited in an X-linked recessive pattern. The skin of patients with this form of Ehlers-Danlos syndrome is highly extensible, and orthopedic abnormalities are common. Bruising and hyperextensibility are rare.
Type VI - Ocular form
Type VI, the ocular form, affects 2% of patients and is inherited in an autosomal recessive pattern. Patients with this type are clinically and severely affected by the disease. The skin is extensible, bruises are common, and wound healing is poor. Patients may have several scars, some of which can be hyperpigmented. The joints are hyperextensible.
This subgroup has unique ocular clinical signs. The ocular fragility can cause retinal hemorrhage and detachment, glaucoma, and coloration of the sclera. Rupture of the globe is rare but possible.
Measurements of LH in the amniotic fluid can be used to predict the outcome of pregnancy.
Type VII - Arthrochalasis multiplex congenita
Type VII, or arthrochalasis multiplex congenita, affects 3% of patients and is inherited in an autosomal recessive or autosomal dominant pattern. Patients with this type have noticeable joint hyperextensibility, but skin changes are less severe than those of other types. Patients have spontaneous joint dislocation, usually with rapid reduction. Patients with this type are usually short in stature.
Type VIII - Periodontal form
Type VIII, the periodontal form, is rare and inherited in an autosomal dominant pattern. Patients with this type have dental involvement with gingival periodontal inflammation. Skin laxity, joint hyperextensibility, and bruisability are variable. Gingival resorption and permanent loss of the teeth are common by the time the patient is aged 30 years.
A review of Ehlers-Danlos syndrome type VIII showed distinctive clinical features. The precise underlying molecular defect is unknown, but patients with this type are similar clinically.
Type IX - X-linked cutis laxa
Type IX, or X-linked cutis laxa, is rare and inherited in an X-linked recessive pattern. Patients with type IX have characteristic bilateral bony prominences on the occiput. Rarely, the skin and joints are dramatically affected. Chronic diarrhea and orthostatic hypotension are unique findings in this group. Scars are usually evident because healing is poor. Patients with this type have a defect in intracellular copper-dependent enzymes, similar to that of patients with Menkes syndrome.
Type X (fibronectin deficiency) and type XI (benign hypermobile joint syndrome)
Type X (fibronectin deficiency) and type XI (benign hypermobile joint syndrome) are rare forms of Ehlers-Danlos syndrome. Some suggest that these types are so similar that they are better classified as one type rather than 2.
In 1997, a new, simpler classification was proposed in an attempt to eliminate the confusion associated with the former classification. Although many dermatology books continue to include both classifications, the Ehlers-Danlos syndrome clinical forms can now be classified as follows:
Classic type was formerly types I and II.
Hypermobility type was formerly type III.
Vascular type was formerly type IV.
Kyphoscoliosis type was formerly type VI.
Arthrochalasis type was formerly type VII, characterized by deficiency of proA1 or proA2 chains of collagen type I.
Dermatosparaxis type was formerly type VII, characterized by deficiency of procollagen N -terminal peptidase.
Other was formerly types V, VIII, IX, X and XI.
Collagens are a family of proteins that are widely distributed in all organs of the body. Thirteen different subtypes are known, and the number increases constantly. The joints, blood vessels, and skin have different kinds of collagen in their structure; in all these locations, collagen is organized into bundles.
Collagen organization is not easily visible by means of light microscopy, and abnormalities are better detected with electron microscopy. Collagen disorganization and/or abnormal bundle size is correlated with clinical evidence in the joints, skin, and blood vessels.
In Ehlers-Danlos syndrome, skin collagen alteration can be seen in the reticular dermis. Two abnormalities are evident: irregularities in the diameter of the fibrils and irregular collagen shapes. Fibrils can be large and irregular in some types (types I-III), but they can also be small or varied in others. The most severe form of Ehlers-Danlos syndrome, type IV, is the best studied; biochemically, this type has decreased or absent type III collagen synthesis. Pathologic findings in other skin layers are visible but nonspecific.
Eder J, Laccone F, Rohrbach M, Giunta C, Aumayr K, Reichel C, et al. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. Exp Dermatol. 2013 Mar. 22 (3):231-4. [Medline].
Schwarze U, Atkinson M, Hoffman GG, Greenspan DS, Byers PH. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet. 2000 Jun. 66 (6):1757-65. [Medline].
Bouma P, Cabral WA, Cole WG, Marini JC. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II. J Biol Chem. 2001 Apr 20. 276 (16):13356-64. [Medline].
Wenstrup RJ, Florer JB, Willing MC, Giunta C, Steinmann B, Young F, et al. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet. 2000 Jun. 66 (6):1766-76. [Medline].
Sun M, Connizzo BK, Adams SM, Freedman BR, Wenstrup RJ, Soslowsky LJ, et al. Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype. Am J Pathol. 2015 May. 185 (5):1436-47. [Medline].
Yeowell HN, Walker LC. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Mol Genet Metab. 2000 Sep-Oct. 71 (1-2):212-24. [Medline].
Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med. 2001 Oct 18. 345 (16):1167-75. [Medline].
Boudko SP, Engel J, Okuyama K, Mizuno K, Bächinger HP, Schumacher MA. Crystal structure of human type III collagen Gly991-Gly1032 cystine knot-containing peptide shows both 7/2 and 10/3 triple helical symmetries. J Biol Chem. 2008 Nov 21. 283 (47):32580-9. [Medline].
Okamoto O, Ando T, Watanabe A, Sato F, Mimata H, Shimada T, et al. A novel point mutation in type III collagen gene resulting in exon 24 skipping in a case of vascular type Ehlers-Danlos syndrome. Arch Dermatol Res. 2008 Oct. 300 (9):525-9. [Medline].
Viglio S, Zoppi N, Sangalli A, Gallanti A, Barlati S, Mottes M, et al. Wound repair capability in EDS fibroblasts can be retrieved by exogenous type V collagen. ScientificWorldJournal. 2008 Oct 3. 8:956-8. [Medline].
Kuz'mina NS, Shipaeva EV, Semyachkina AN, Vasil'eva IM, Kovalenko LP, Durnev AD, et al. Polymorphism of detoxification genes and cell resistance to mutagens in patients with Ehlers-Danlos syndrome. Bull Exp Biol Med. 2007 Nov. 144 (5):717-21. [Medline].
Murray ML, Yang M, Fauth C, Byers PH. FKBP14-related Ehlers-Danlos syndrome: expansion of the phenotype to include vascular complications. Am J Med Genet A. 2014 Jul. 164A (7):1750-5. [Medline].
Bethea BT, Fitton TP, Alejo DE, Barreiro CJ, Cattaneo SM, Dietz HC, et al. Results of aortic valve-sparing operations: experience with remodeling and reimplantation procedures in 65 patients. Ann Thorac Surg. 2004 Sep. 78 (3):767-72; discussion 767-72. [Medline].
Remvig L, Flycht L, Christensen KB, Juul-Kristensen B. Lack of consensus on tests and criteria for generalized joint hypermobility, Ehlers-Danlos syndrome: hypermobile type and joint hypermobility syndrome. Am J Med Genet A. 2014 Mar. 164A (3):591-6. [Medline].
Castori M, Dordoni C, Morlino S, Sperduti I, Ritelli M, Valiante M, et al. Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet. 2015 Mar. 169C (1):43-53. [Medline].
Yassin OM, Rihani FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent. 2006 Summer. 30 (4):337-41. [Medline].
van Bon AC, Kristinsson JO, van Krieken JH, Wanten GJ. Concurrent splenic peliosis and vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2009 Mar. 23 (2):256.e1-4. [Medline].
Guala A, Viglio S, Ottinetti A, Angeli G, Canova G, Colombo E, et al. Cutaneous metaplastic synovial cyst in Ehlers-Danlos syndrome: report of a second case. Am J Dermatopathol. 2008 Feb. 30 (1):59-61. [Medline].
Vilisaar J, Harikrishnan S, Suri M, Constantinescu CS. Ehlers-Danlos syndrome and multiple sclerosis: a possible association. Mult Scler. 2008 May. 14 (4):567-70. [Medline].
Perrinaud A, Matos M, Maruani A, Mondon K, Machet L. [Absence of inferior labial or lingual frenula in Ehlers-Danlos syndrome: a new diagnostic criterion?]. Ann Dermatol Venereol. 2007 Nov. 134 (11):859-62. [Medline].
Baba CS, Sharma PK, Deo V, Pal S, Sethuraman G, Gupta SD, et al. Association of Ehlers-Danlos syndrome and solitary rectal ulcer syndrome. Indian J Gastroenterol. 2007 May-Jun. 26 (3):149-50. [Medline].
Savasta S, Crispino M, Valli M, Calligaro A, Zambelloni C, Poggiani C. Subependymal periventricular heterotopias in a patient with ehlers-danlos syndrome: a new case. J Child Neurol. 2007 Mar. 22 (3):317-20. [Medline].
Miles SC, Robinson PD, Miles JL. Ehlers–Danlos syndrome and anorexia nervosa: a dangerous combination?. Pediatr Dermatol. 2007 May-Jun. 24 (3):E1-4. [Medline].
Kundu AK, Chattopadhyay P, Kundu S, Choudhury S. Pregnancy in Ehlers-Danlos syndrome. J Assoc Physicians India. 2006 Dec. 54:938. [Medline].
Atzinger CL, Meyer RA, Khoury PR, Gao Z, Tinkle BT. Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome. J Pediatr. 2011 May. 158 (5):826-830.e1. [Medline].
Dordoni C, Ritelli M, Venturini M, Chiarelli N, Pezzani L, Vascellaro A, et al. Recurring and generalized visceroptosis in Ehlers-Danlos syndrome hypermobility type. Am J Med Genet A. 2013 May. 161A (5):1143-7. [Medline].
Hamonet C, Frédy D, Lefèvre JH, Bourgeois-Gironde S, Zeitoun JD. Brain injury unmasking Ehlers-Danlos syndromes after trauma: the fiber print. Orphanet J Rare Dis. 2016 Apr 22. 11:45. [Medline].
Aalberts JJ, van den Berg MP, Bergman JE, du Marchie Sarvaas GJ, Post JG, van Unen H, et al. The many faces of aggressive aortic pathology: Loeys-Dietz syndrome. Neth Heart J. 2008 Sep. 16 (9):299-304. [Medline].
Castori M. Ehlers-Danlos syndrome(s) mimicking child abuse: Is there an impact on clinical practice?. Am J Med Genet A. 2016 May 5. [Medline].
Umekoji A, Fukai K, Hosomi N, Ishii M, Tanaka A, Murakami K, et al. Vascular type of Ehlers-Danlos syndrome associated with mild haemophilia A. Clin Exp Dermatol. 2009 Jan. 34 (1):101. [Medline].
Rombaut L, Malfait F, De Wandele I, Cools A, Thijs Y, De Paepe A, et al. Medication, surgery, and physiotherapy among patients with the hypermobility type of Ehlers-Danlos syndrome. Arch Phys Med Rehabil. 2011 Jul. 92 (7):1106-12. [Medline].
Alkadhi H, Wildermuth S, Desbiolles L, Schertler T, Crook D, Marincek B, et al. Vascular emergencies of the thorax after blunt and iatrogenic trauma: multi-detector row CT and three-dimensional imaging. Radiographics. 2004 Sep-Oct. 24 (5):1239-55. [Medline].
Monroe GR, Harakalova M, van der Crabben SN, Majoor-Krakauer D, Bertoli-Avella AM, Moll FL, et al. Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1. Am J Med Genet A. 2015 Jun. 167 (6):1196-203. [Medline].
Fernández-Alcantud J, López RC, Osado IR, Castro MR. [Management of anesthesia in vascular-type Ehlers-Danlos syndrome (type IV)]. Rev Esp Anestesiol Reanim. 2008 May. 55 (5):312-3. [Medline].
Jones TL, Ng C. Anaesthesia for caesarean section in a patient with Ehlers-Danlos syndrome associated with postural orthostatic tachycardia syndrome. Int J Obstet Anesth. 2008 Oct. 17 (4):365-9. [Medline].
Faber P, Craig WL, Duncan JL, Holliday K. The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome. Acta Anaesthesiol Scand. 2007 Oct. 51 (9):1277-9. [Medline].
Sinibaldi L, Ursini G, Castori M. Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers-Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revised. Am J Med Genet C Semin Med Genet. 2015 Mar. 169C (1):97-106. [Medline].